JP2019534883A5 - - Google Patents

Download PDF

Info

Publication number
JP2019534883A5
JP2019534883A5 JP2019519219A JP2019519219A JP2019534883A5 JP 2019534883 A5 JP2019534883 A5 JP 2019534883A5 JP 2019519219 A JP2019519219 A JP 2019519219A JP 2019519219 A JP2019519219 A JP 2019519219A JP 2019534883 A5 JP2019534883 A5 JP 2019534883A5
Authority
JP
Japan
Prior art keywords
acceptable salt
pharmaceutically acceptable
stereoisomer
item
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019519219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019534883A (ja
JP7034152B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/055109 external-priority patent/WO2018067685A1/en
Publication of JP2019534883A publication Critical patent/JP2019534883A/ja
Publication of JP2019534883A5 publication Critical patent/JP2019534883A5/ja
Application granted granted Critical
Publication of JP7034152B2 publication Critical patent/JP7034152B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019519219A 2016-10-05 2017-10-04 小分子ａｍｐｋ活性化剤 Active JP7034152B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662404592P 2016-10-05 2016-10-05
US62/404,592 2016-10-05
PCT/US2017/055109 WO2018067685A1 (en) 2016-10-05 2017-10-04 Small molecule ampk activators

Publications (3)

Publication Number Publication Date
JP2019534883A JP2019534883A (ja) 2019-12-05
JP2019534883A5 true JP2019534883A5 (https=) 2020-11-12
JP7034152B2 JP7034152B2 (ja) 2022-03-11

Family

ID=61832129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019519219A Active JP7034152B2 (ja) 2016-10-05 2017-10-04 小分子ａｍｐｋ活性化剤

Country Status (8)

Country Link
US (2) US11040935B2 (https=)
EP (1) EP3522877B1 (https=)
JP (1) JP7034152B2 (https=)
KR (1) KR20190096949A (https=)
CN (1) CN110035745B (https=)
AU (1) AU2017340403B2 (https=)
RU (1) RU2766146C2 (https=)
WO (1) WO2018067685A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11040935B2 (en) 2016-10-05 2021-06-22 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecule AMPK activators
EP4027987A4 (en) * 2019-09-10 2023-11-29 University of Pittsburgh - Of the Commonwealth System of Higher Education Methods and materials for increasing level of phosphorylated ampk protein
CN111925345B (zh) * 2020-08-21 2023-09-29 上海科利生物医药有限公司 一种手性2-氨甲基四氢呋喃的制备方法
EP4479366A4 (en) * 2022-02-15 2026-03-25 Childrens Medical Ct Corp COMPOSITIONS AND METHODS RELATING TO THE INHIBITION OF ATP/P2X7R SIGNALING

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2547524A1 (de) * 1975-10-23 1977-04-28 Bayer Ag Disubstituierte phenolaether des 3-amino-2-hydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5726653A (en) * 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
US4410472A (en) 1982-01-15 1983-10-18 Aluminum Company Of America Method for making spherical binderless pellets
US4552960A (en) 1983-06-20 1985-11-12 Eli Lilly And Company Fungicidal amines
DE4017019A1 (de) 1990-05-26 1991-11-28 Hoechst Ag Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen
TW205034B (https=) * 1990-09-13 1993-05-01 Pola Kasei Kogyo Kk
EP0533056A3 (en) 1991-09-14 1993-06-16 Hoechst Aktiengesellschaft Substituted aminopropanes, process for their preparation and their use as antimycotic agents
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
WO2000073302A1 (en) * 1999-05-27 2000-12-07 3-Dimensional Pharmaceuticals, Inc. Oxazaheterocycles as protease inhibitors
AUPQ841300A0 (en) * 2000-06-27 2000-07-20 Fujisawa Pharmaceutical Co., Ltd. New aminoalcohol derivatives
US6395762B1 (en) * 2000-07-17 2002-05-28 American Home Products Corporation Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
CA2415932A1 (en) 2000-07-17 2002-01-24 3-Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine pyrazinones as protease inhibitors
WO2003024953A1 (en) * 2000-08-10 2003-03-27 Nisshin Pharma Inc. Propanolamine derivative having 1,4-benzodioxane ring
AR035605A1 (es) 2000-12-11 2004-06-16 Bayer Corp Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores
WO2002098832A1 (de) * 2001-06-05 2002-12-12 Merck Patent Gmbh Cf2o-verbrückte, axial substituierte cyclohexan-derivate
US20030158195A1 (en) 2001-12-21 2003-08-21 Cywin Charles L. 1,6 naphthyridines useful as inhibitors of SYK kinase
AU2003226094A1 (en) 2002-03-27 2003-10-13 Smithkline Beecham Corporation Compounds and methods
EP1754483A1 (en) * 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
JP2009536613A (ja) * 2006-04-07 2009-10-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を調節する化合物
ITMI20061581A1 (it) * 2006-08-04 2008-02-05 Univ Bari Ligandi del recettore beta-3 adrenergico e loro uso in terapia
JP2010527980A (ja) 2007-05-22 2010-08-19 プロシディオン・リミテッド 代謝障害を治療するための二環状アリールおよびヘテロアリール化合物
WO2010003084A2 (en) * 2008-07-02 2010-01-07 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
US20100279997A1 (en) 2009-05-04 2010-11-04 Lindsay Burns Barbier Analgesic that binds filamin a
JP6566867B2 (ja) 2012-07-13 2019-08-28 ペイン セラピューティクス インコーポレイテッド 生きている患者でのアルツハイマー病アッセイ
ES2716049T3 (es) 2012-07-13 2019-06-07 Pain Therapeutics Inc Un método para inhibir la fosforilación de tau
EP2983473A4 (en) 2013-03-15 2016-11-23 Als Mountain Llc PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONINERGIC AGENT AND METHODS OF USING SAME
US9433604B2 (en) 2013-10-08 2016-09-06 Pain Therapeutics Inc. Method for inhibiting growth of cancer cells
US11040935B2 (en) 2016-10-05 2021-06-22 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecule AMPK activators

Similar Documents

Publication Publication Date Title
JP2019534883A5 (https=)
JP2016518430A5 (https=)
JP2013508288A5 (https=)
JP2015520143A5 (https=)
JP2011037841A5 (https=)
RU2011102587A (ru) Дизамещенные фенильные соединения
JP2010535722A5 (https=)
JP2015531371A5 (https=)
JP2014517017A5 (ja) 化合物、その医薬組成物、及び癌治療用の阻害薬としてのその使用
DE05705627T1 (de) Trägerampholyte mit hohem ph-wert-bereich
JP2011137045A5 (https=)
JP2019513770A5 (https=)
RU2018110372A (ru) Полоски с хирургическими скобами, допускающие наличие скоб с переменными свойствами и обеспечивающие простую загрузку кассеты
RU2012123154A (ru) Способы лечения синдрома фибромиалгии
ME02754B (me) Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
RU2016118399A (ru) Производные 4-аминометилбензойной кислоты
AR082519A1 (es) Fenilamidinas que tienen alta actividad fungicida, y su utilizacion
RU2015131103A (ru) Синергические фунгицидные смеси для борьбы с грибковыми болезнями злаков
JP2002512243A5 (https=)
JPWO2021069705A5 (https=)
RU2015122126A (ru) Производное пиррол сульфонамида, метод его получения и применение в медицине
JP2017521436A5 (https=)
JP2013533253A5 (https=)
RU2017115809A (ru) Комбинированная терапия ингибиторами с-с хемокинового рецептора 9 (ccr9) и антителами, блокирующими альфа4бета7-интегрин
RU2019113149A (ru) Низкомолекулярные активаторы амфк